Henry Schein Reaches New 52-Week High (HSIC)

NEW YORK ( TheStreet) -- Henry Schein (Nasdaq: HSIC) hit a new 52-week high Friday as it is currently trading at $77.06, above its previous 52-week high of $77.05 with 177,863 shares traded as of 1:19 p.m. ET. Average volume has been 464,800 shares over the past 30 days.

Henry Schein has a market cap of $6.83 billion and is part of the services sector and wholesale industry. Shares are up 18.6% year to date as of the close of trading on Thursday.

Henry Schein, Inc. distributes healthcare products and services primarily to office-based healthcare practitioners. It operates in two segments, Healthcare Distribution and Technology. The company has a P/E ratio of 19.1, equal to the average wholesale industry P/E ratio and above the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Henry Schein as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, growth in earnings per share, increase in net income, solid stock price performance and good cash flow from operations. We feel these strengths outweigh the fact that the company shows low profit margins. You can view the full Henry Schein Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.

null

More from Markets

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

CBS-Viacom Battle Comes to a Head; FDA Approves Novartis Migraine Drug --ICMYI

CBS-Viacom Battle Comes to a Head; FDA Approves Novartis Migraine Drug --ICMYI

Listen: Here's What You Need To Know About ETFs Today (Hint: They're on Fire!)

Listen: Here's What You Need To Know About ETFs Today (Hint: They're on Fire!)

Cramer and His Team Stick to Their Disciplines -- Even When It's Disappointing

Cramer and His Team Stick to Their Disciplines -- Even When It's Disappointing